Loss of function mutations preventing kinase activity of RIPK1 itself as well as heterozygous Casp8 cleavage-site mutations allowing unregulated activity of RIPK1 cause severe primary immunodeficiency, intestinal inflammation, arthritis, and CRIA in humans (1, 30). The gene discussed is RIPK1; the disease is arthritic joint disease.